Canada markets closed

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.5900+0.0100 (+0.39%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
13,110
13,110
7,839
8,765
8,205
Selling General and Administrative
8,157
8,157
6,162
4,881
4,494
Total Operating Expenses
21,267
21,267
14,001
13,646
12,494
Operating Income or Loss
-21,267
-21,267
-14,001
-13,646
-12,494
Total Other Income/Expenses Net
1,929
1,929
353
82
229
Income Before Tax
-19,338
-19,338
-13,648
-13,564
-12,265
Income Tax Expense
43
43
28
28
27
Income from Continuing Operations
-19,381
-19,381
-13,676
-13,592
-12,292
Net Income
-19,381
-19,381
-13,676
-13,592
-12,292
Net Income available to common shareholders
-19,381
-19,381
-13,676
-13,592
-12,292
Basic EPS
-0.78
-0.60
-0.52
-0.65
-0.78
Diluted EPS
-0.78
-0.60
-0.52
-0.65
-0.78
Basic Average Shares
15,680
32,567
26,443
20,773
15,680
Diluted Average Shares
15,680
32,567
26,443
20,773
15,680